Four of the most challenging issues facing those who work in clinical trials in biotechnology were discussed by four prominent people working in the field today. This paper presents the perspective of the pharmaceutical industry on the papers presented by Drs. Gary Koch, Jonas Ellenberg, Tom Fleming, and Susan Ellenberg.
